# Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/treatment-driven-tumour-heterogeneity-and-drug-resistance-lessons-from-solid/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Stefania Crucitta,Federico Cucchiara,Ron H.J. Mathijssen,Joaquı́n Mateo,Agnes Jager,Arjen Joosse,Antonio Passaro,Ilaria Attili,Iacopo Petrini,Ron HN van Schaik,Romano Danesi,Marzia Del Re |
| Citations | 95 |
| DOI | 10.1016/j.ctrv.2022.102340 |
| Fields | Computer Science,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://pure.eur.nl/en/publications/dbf40080-4243-494f-bfef-6bdfa1a880dd |
| OpenAlex ID | https://openalex.org/W4210752699 |
| PMID | 35151155 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Iacopo Petrini](https://scholariq.org/researchers/iacopo-petrini/)

## Paper primary topic

- [Computational Drug Discovery Methods](https://scholariq.org/topics/computational-drug-discovery-methods/)

## Paper topics

- [Computational Drug Discovery Methods](https://scholariq.org/topics/computational-drug-discovery-methods/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.